Skip to main content

TEVA 5294 Pill - purple white capsule/oblong, 19mm

Pill with imprint TEVA 5294 is Purple / White, Capsule/Oblong and has been identified as Omeprazole Delayed-Release 40 mg. It is supplied by Teva Pharmaceuticals USA, Inc.

Omeprazole is used in the treatment of Barrett's Esophagus; Erosive Esophagitis; GERD; Duodenal Ulcer; Helicobacter Pylori Infection and belongs to the drug class proton pump inhibitors. Risk cannot be ruled out during pregnancy. Omeprazole 40 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 5294

Omeprazole delayed-release 40 mg TEVA 5294
Omeprazole delayed-release 40 mg TEVA 5294

Omeprazole Delayed-Release

TEVA 5294
40 mg
Purple / White
19.00 mm
Rx and/or OTC
Drug Class
Proton pump inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceutical Industries, Ltd.
National Drug Code (NDC)
00093-5294 (Discontinued)
Inactive Ingredients
ferrosoferric oxide, FD&C Blue No. 1, FD&C Red No. 40, hypromellose 2910 (6 mPa.s), methacrylic acid - ethyl acrylate copolymer (1:1) type a, polyethylene glycol 6000, potassium hydroxide, povidone k30, propylene glycol, shellac, sodium lauryl sulfate, corn starch, sucrose, titanium dioxide, triethyl citrate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.